DNSP-11 10mg is a high-purity nootropic peptide API, synthesized from the proGDNF domain with 11 amino acids (sequence: PPEAPAEDRSL-NH2). This peptide is specifically designed to protect and stimulate dopamine neurons, with neuroprotective effects against oxidative stress and toxic factors.
Research shows DNSP-11 can significantly reduce caspase-3/7 activation in dopaminergic cells, protecting them from apoptosis. It has demonstrated efficacy in animal models of Parkinson’s disease, restoring dopaminergic activity and improving motor function. Ideal for pharmaceutical manufacturers and research institutions focusing on neurodegenerative diseases and cognitive health.
This API features high purity (≥98%), excellent water solubility, and stable peptide structure, making it suitable for various research applications. Its neuroprotective properties make it a valuable raw material for developing treatments for Parkinson’s disease, traumatic brain injury, and other dopamine-related neurological disorders.
